Chronic Spontaneous Urticaria: How to Measure It and the Need to Define Treatment Success by April W. Armstrong, Weily Soong, Jonathan A. Bernstein

Connect to this object online.

Development and validation of the angiotensin-converting enzyme inhibitor (ACEI) induced angioedema investigator rating scale and proposed discharge criteria by Nicola Bonner, Charlotte Panter, Alan Kimura, Rich Sinert, Joseph Moellman, Jonathan A. Bernstein

Connect to this object online.

Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status by Thomas B. Casale, Ana Maria Gimenez-Arnau, Jonathan A. Bernstein, Michael Holden, Torsten Zuberbier, Marcus Maurer

Connect to this object online.

Challenges in the Use of the Treat-to-Target Strategy in Atopic Dermatitis in Latin America: A Case Series Review by Ivan Cherrez-Ojeda, Karla Robles-Velasco, Simon Francis Thomsen, German D. Ramon, Jorge Sánchez, Jonathan A. Bernstein, Benjamin Hidalgo

Connect to this object online.

UCOMB-real life data: treatment strategies for chronic urticaria patients with comorbidities by Petra Staubach, Benedikt Bilo, Joachim W. Fluhr, Karoline Krause, Kanokvalai Kulthanan, Andac Salman, Connie Katelaris, Jonathan A. Bernstein, Marcus Maurer, Caroline Mann

Connect to this object online.